NDC codes

FDA NDC Directory
Product NDC (as listed)68547-915Labeler and product segments. Claims need a package NDC.
Product NDC at billing width68547-0915Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
68547-915-10685470915101 PACKET in 1 CARTON (68547-915-10) / 1 FOR SUSPENSION in 1 PACKETMarketed from Apr 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Nuzolvence
Generic name (nonproprietary)
zoliflodacin
Active ingredients
Zoliflodacin — 3 g/1
Dosage form
For suspension
Route
Oral
Labeler
La Jolla Pharmaceutical CompanyNDC labeler code 68547
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 219491
Marketing start
Listing expires
Identifiers
Product ID 68547-915_1835ee35-6c63-46c0-856f-6205e76af7b9SPL ID 1835ee35-6c63-46c0-856f-6205e76af7b9SPL set ID 4beda35a-21b0-4b34-84ea-be6ea8cae50fRxCUI 2739783, 2739789UNII FWL2263R77

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468547091510 followed by a unit qualifier and the quantity

Package 68547-0915-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

NUZOLVENCE is a spiropyrimidinetrione bacterial type II topoisomerase inhibitor indicated for the treatment of uncomplicated urogenital gonorrhea due to Neisseria gonorrhoeae in adults and pediatric patients 12 years of age and older, weighing at least 35 kg. ( 1.1 ) Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant bacteria and maintain the effectiveness of NUZOLVENCE and other antibacterial drugs, NUZOLVENCE should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. ( 1.2 ) 1.1 Uncomplicated Urogenital Gonorrhea NUZOLVENCE is indicated for the treatment of uncomplicated urogenital gonor…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68547-915

What is NDC 68547-915?
68547-915 is the product NDC for Nuzolvence (zoliflodacin), Zoliflodacin 3 g/1 for suspension, listed with the FDA by La Jolla Pharmaceutical Company. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Nuzolvence (Zoliflodacin).
What is the active ingredient?
Zoliflodacin.
Who is the labeler?
La Jolla Pharmaceutical Company, NDC labeler code 68547. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Nuzolvence?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in